Pressure Gradient vs. Flow Relationships in Patients With Symptomatic Valvular Aortic Stenosis
NCT ID: NCT05580237
Last Updated: 2024-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2019-09-01
2023-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Valvular Aortic Stenosis Prognosis Study
NCT03628313
Low Flow Low Gradient Aortic Stenosis Relevance of the (re)Search for a Contractile Reserve
NCT02727504
Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly(Mrs AVS)
NCT03797820
Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis
NCT04613193
The Role of Cardiac Mechanics, Biomarkers and Frailty in Aortic Stenosis
NCT02856620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Severe aortic valve stenosis
Simultaneous right and left heart catheterization
Pressure recordings across the aortic valve with simultaneous flow measurements by right heart catheterization, during rest and during supine exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Simultaneous right and left heart catheterization
Pressure recordings across the aortic valve with simultaneous flow measurements by right heart catheterization, during rest and during supine exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* LVEF \> 50 %
* AVA \< 1.0 cm2
* Symptomatic - at least equivalent to NYHA functional class II
Exclusion Criteria
* Severe coronary artery disease (main stem, proximal LAD or 3 vessel disease)
* Moderate or severe aortic valve regurgitation
* Moderate or severe mitral valve regurgitation or stenosis
* Moderate or severe pulmonary valve regurgitation or stenosis
* Moderate or severe tricuspid valve regurgitation or stenosis
* Severe pulmonary hypertension (tricuspid valve pressure gradient of 60 mmHg)
* Right ventricular dysfunction (TAPSE \< 17 mm)
* Restrictive cardiomyopathy or cardiac amyloidosis
* Constrictive pericarditis
* Inability to perform supine bicycle exercise
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital Skejby
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Henrik Vase
Staff Specialist, MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henrik Vase, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology, Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-71-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.